SCHEMBL492893

SCHEMBL492893

CN(C)C(c1ccccc1)C1CCC(CNC(=O)COC2CCCCC2N(C)S(=O)(=O)c2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SPPL2A Q8TCT8 8/20 0.40
PSEN1 P49768 6/20 0.40
PSEN2 P49810 6/20 0.40
APH1B Q8WW43 6/20 0.40
NCSTN Q92542 6/20 0.40
APH1A Q96BI3 6/20 0.40
PSENEN Q9NZ42 6/20 0.40
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
BACE1 P56817 2/20 0.36
PTGIR P43119 1/20 0.34
ALDH1A1 P00352 1/20 0.34
RECQL P46063 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL492674 0.95 KMT2A (0.37) SPPL2APSEN1PSEN2APH1BNCSTN
SCHEMBL492897 0.93 KMT2A (0.36) SPPL2APSEN1PSEN2APH1BNCSTN
SCHEMBL493357 0.93 PSEN1 (0.36) SPPL2APSEN1PSEN2APH1BNCSTN
SCHEMBL492539 0.89 KMT2A (0.43) SPPL2APSEN1PSEN2APH1BNCSTN
SCHEMBL493145 0.89 ALDH1A1 (0.35) SPPL2APSEN1PSEN2APH1BNCSTN
SCHEMBL492584 0.87 PSEN1 (0.34) SPPL2APSEN1PSEN2APH1BNCSTN
SCHEMBL492864 0.87 KMT2A (0.37) SPPL2APSEN1PSEN2APH1BNCSTN
SCHEMBL492802 0.86 LMNA (0.34) SPPL2APSEN1PSEN2APH1BNCSTN
SCHEMBL492745 0.83 KMT2A (0.41) SPPL2APSEN1PSEN2APH1BNCSTN
SCHEMBL493484 0.82 KMT2A (0.40) SPPL2APSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD SPPL2A 3009/4885PSEN1 3663/4885PSEN2 2905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.